Pulmonary Hypertension (PH) Completed Phase 3 Trials for Treprostinil (DB00374)

Also known as: Pulmonary; Hypertension / Hypertension Pulmonary / Hypertension, Pulmonary / Pulmonary hypertensions / Pulmonary Hypertension / Other secondary pulmonary hypertension / Pulmonary hypertension NOS

IndicationStatusPhase
DBCOND0051788 (Pulmonary Hypertension (PH))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00887978Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial HypertensionTreatment
NCT00325403FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)Treatment
NCT00325442FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH)Treatment
NCT00147199Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH)Treatment
NCT00004497Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary HypertensionTreatment